Genetic and epigenetic features in radiation sensitivity: Part II: Implications for clinical practice and radiation protection

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 3, 2005, Pages 351-368

  Bourguignon, Michel H ^a,b   Gisone, Pablo A ^c   Perez, Maria R ^c   Michelin, Severino ^c   Dubner, Diana ^c   Di Giorgio, Marina ^c   Carosella, Edgardo D ^b  

^a Dir Gen Surete Nucl R   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Autoridad Regulatoria Nuclear   (Argentina)

Author keywords

Epigenetic disorders; Genetic disorders; Radiation protection; Radiation sensitivity

Indexed keywords

APLASTIC ANEMIA; APOPTOSIS; ATAXIA TELANGIECTASIA; BASAL CELL NEVUS SYNDROME; BECKWITH WIEDEMANN SYNDROME; BILE DUCT CARCINOMA; BLOOM SYNDROME; BRAIN CANCER; BRAIN TUMOR; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CLONOGENESIS; COCKAYNE SYNDROME; COLON CARCINOMA; COLORECTAL CANCER; COMBINED IMMUNODEFICIENCY; COMET ASSAY; CYTOGENETICS; DISEASE ASSOCIATION; DNA DAMAGE; DYSKERATOSIS CONGENITA; ENDOMETRIUM CARCINOMA; EPIGENETICS; FAMILIAL CANCER; FAMILIAL DISEASE; FANCONI ANEMIA; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HYPERSENSITIVITY; IONIZING RADIATION; LEUKEMIA; LYMPHOMA; MEDICAL ETHICS; MELANOMA; MICRONUCLEUS TEST; MOLECULAR BIOLOGY; NIJMEGEN BREAKAGE SYNDROME; NUCLEAR MEDICINE; OSTEOSARCOMA; OVARY CARCINOMA; PRACTICE GUIDELINE; PROGERIA; PULSED FIELD GEL ELECTROPHORESIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RADIATION RESPONSE; RADIATION SICKNESS; RADIOSENSITIVITY; RETINOBLASTOMA; REVIEW; ROTHMUND THOMSON SYNDROME; SARCOMA; SECKEL SYNDROME; SKIN CARCINOMA; SMALL INTESTINE CARCINOMA; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; TRICHOTHIODYSTROPHY; URINARY TRACT CARCINOMA; WERNER SYNDROME; XERODERMA PIGMENTOSUM; XERODERMA PIGMENTOSUM VARIANT;

EPIGENESIS, GENETIC; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RADIATION INJURIES; RADIATION PROTECTION; RADIATION TOLERANCE; RADIATION, IONIZING; RISK ASSESSMENT; RISK FACTORS;

EID: 17644415325     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1731-6     Document Type: Review

References (117)

1. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K. Signal transduction and cellular radiation responses. Radiat Res 2000;153:245-47.
2. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, et al. Stress and radiation-induced activation of multiple intracellular signalling pathways. Radiat Res 2003;159:283-300.
3. Twardella D, Chang-Claude J. Studies on radiosensitivity from an epidemiological point of view - overview of methods and results. Radiother Oncol 2002;62:249-60.
4. Turreson I, Nyman J, Holmberg E, Odén A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-75.
5. Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Di Giorgio M, et al. Genetic and epigenetic features in radiation sensitivity. Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging 2005;32 (in press).
6. Lehmann AR. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 2003;85:1101-11.
7. Cordonnier AM, Fuchs RP. Replication of damaged DNA: molecular defect in xeroderma pigmentosum variant cells. Mutat Res 1999;435:111-19.
8. Kannouche P, Stary A. Xeroderma pigmentosum variant and error prone DNA polymerases. Biochimie 2003;85:1123-32.
9. Limoli CL, Giedzinski E, Morgan WF, Cleaver JE. Polymerase η deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair. Proc Natl Acad Sci U S A 2000;97:7939-46.
10. Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 1988;336:577-80.
11. Swift M. Genetics and epidemiology of ataxia-telangiectasia. Kroc Found Ser 1985;19:133-46.
12. Taylor AMR. Chromosome instability syndromes. Best Pract Res Clin Haematol 2001;14:631-44.
13. Pandita TK, Pathak S, Geard CR. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet Cell Genet 1995;71:86-93.
14. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 2003;42:643-8.
15. Hecht F, Hecht BK. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet 1990;46:9-19.
16. Weissberg JB, Huang DD, Swift M. Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. Int J Radiat Oncol Biol Phys 1998;42:1133-6.
17. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity Cancer Res 2003;63:8717-25.
18. Petrini JH, Theunissen JW. Double strand break metabolism and cancer susceptibility: lessons from the Mre11 complex. Cell Cycle 2004;3:541-2.
19. Digweed M. Response to environmental carcinogens in DNA-repair-deficient disorders. Toxicology 2003;193:111-24.
20. Roselli F, Briot D, Pichierri P. The Fanconi anemia pathway and the DNA interstrand cross-link repair. Biochimie 2003;85:1175-84.
21. Roselli F, Briot D, Pichieri P. The Fanconi anemia pathway and the DNA interstrand cross-link repair. Biochimie 2003;85:1175-84.
22. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002;297:606-9.
23. Duckworth-Rysiecki G, Taylor AM. Effects of ionizing radiation on cells from Fanconi's anemia patients. Cancer Res 1985;45:416-20.
24. Djuzenova CS, Rothfuss A, Oppitz U, Spelt G, Schindler D, Hoehn H, et al. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest 2001;81:185-92.
25. Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 2002;4:913-20.
26. Kaneko H, Kondo N. Clinical features of Bloom syndrome and function of the causative gene, BLM helicase. Expert Rev Mol Diag 2004;4:393-401.
27. Bhisitkul RB, Rizen M. Bloom syndrome: multiple retinopathies in a chromosome breakage disorder. Br J Ophthalmol 2004;88:354-7.
28. Harrigan JA, Bohr VA. Human diseases deficient in RecQ helicases. Biochimie 2003;85:1185-93.
29. Franchitto A, Pichierri P. Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest. J Cell Biol 2002;157: 19-30.
30. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000;14:927-39.
31. Gaymes TJ, North PS, Brady N, Hickson ID, Mufti GJ, Rassool FV. Increased error-prone non homologous DNA end-joining - a proposed mechanism of chromosomal instability in Bloom's syndrome. Oncogene 2002;21:2525-33.
32. Wang LL, Levy ML, Lewis RA, Chintagumpala MM, Lev D, Rogers M, et al. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Genet 2001;102:11-7.
33. Wang LL, Gannavarapu A, Kozinetz CA, Levy ML, Lewis RA, Chintagumpala MM, et al. Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 2003;95:669-74.
34. Stoll C, Labay F, Geisert J, Alembik Y. Wiedemann-Rautenstrauch syndrome. A case report and review of the literature. Genet Couns 1998;9:119-24.
35. Cao H, Hegele RA. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J Hum Genet 2003;48:271-4.
36. Bridger JM, Kill IR. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 2004;39:717-24.
37. Tuo J, Jaruga P, Rodriguez H, Bohr VA, Dizdaroglu M. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine and 8-hydroxyadenine resulting from oxidative stress. FASEB J 2003;17:668-74.
38. Yamamoto K, Imakiire A, Miyagawa N, Kasahara T. A report of two cases of Werner's syndrome and review of the literature. J Orthop Surg (Hong Kong) 2003;11:224-33.
39. Machwe A, Xiao L. Orren DK TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. Oncogene 2004;23:149-56.
40. Cheng WH, Von Kobbe C, Opresko PL, Arthur LM, Komatsu K, Seidman MM, et al. Linkage between Werner syndrome protein and the Mre11 Complex via Nbs1. J Biol Chem 2004;279:21169-76.
41. Less-Miller SP, Meek k. Repair of DNA double strand breaks by non-homologous end joining. Biochimie 2003;85:1161-73.
42. Dudasova Z, Chovanec M. Artemis, a novel guardian of the genome. Neoplasma 2003;50:311-8.
43. Moshous D, Pannetier C, Chasseval Rd R, Deist Fl F, Cavazzana-Calvo M, Romana S, et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 2003;111:381-7.
44. O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001;8:1175-85.
45. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet 2003;33:497-501.
46. Comolli LR, Smirnov I, Xu L, Blackburn EH, James TL. A molecular switch underlies a human telomerase disease. Proc Natl Acad Sci U S A 2002;99:16998-7003.
47. Dokal I, Bungey J, Williamson P, Oscier D, Hows J, Luzzatto L. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood 1992;80: 3090-6.
48. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997;14:1013-21.
49. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000;110:768-79.
50. DeBauche DM, Pai GS, Stanley WS. Enhanced G2 chromatid radiosensitivity in dyskeratosis congenita fibroblasts. Am J Hum Genet 1990;46:350-7
51. Cengiz M, Celebioglu B, Ozyar E, Lale Atahan I. Unusual hypersensitivity to radiation therapy in a patient with dyskeratosis congenita syndrome. Oral Oncol 2004;40:758-9.
52. M'kacher R, Laithier V, Valent A, Delhommeau F, Violot D, Deutsch E, et al. Sensitivity to radiation and alkylating agent of peripheral lymphocytes and fibroblasts in a Hoyeraal-Hreidarsson syndrome patient. Pediat Hematol Oncol 2003;20:651-6.
53. Rebbeck TR. Biomarkers of inherited susceptibility and cancer. IARC Sci Publ 2004;157:91-103.
54. Barros RA, Ciammella SM, Schinoni MI. Hereditary familial non polypoid colorectal cancer. Acta Gastroenterol Latinoam 2001;31:23-6.
55. Mamon H, Dahlberg W, Little JB. Hemizygous fibroblast cell strains established from patients with BRCA1 or BRCA2 mutations demonstrate an increased rate of spontaneous mutations and increased radiosensitivity. Int J Radiat Oncol Biol Phys 2003;57:S346-7.
56. Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 2003;63:2440-6.
57. Chang EH, Pirollo KF, Zou ZQ, Cheung HY, Lawler EL, Garner R, et al. Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family. Science 1987;237:1036-9.
58. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004;96:357-63.
59. Manfredi M, Vescovi P, Bonanini M, Porter S. Nevoid basal cell carcinoma syndrome: a review of the literature. Int J Oral Maxillofac Surg 2004;33:117-24.
60. Bisogno G, Sotti G, Nowicki Y, Ferrari A, Garaventa A, Zanetti I, et al. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group. Cancer 2004;100:1758-65.
61. Robbins JH, Otsuka F, Tarone RE, Polinsky RJ, Brumback RA, Nee LE. Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines. Neurol Neurosurg Psychiatry 1985;48:916-23.
62. Chen P, Kidson C, Lavin M. Heterogeneity in Alzheimer's disease: evidence from cellular radiosensitivity and complementation of this phenotype. Mutat Res 1991;256:21-7.
63. Real F, Krown SE, Nisce LZ, Oettgen HF. Unexpected toxicity from radiation therapy in two patients with Kaposi's sarcoma receiving interferon. J Biol Resp Modif 1985;4:141-6.
64. Hughes-Davies L, Young T, Spittle M. Radiosensitivity in AIDS patients. Lancet 1991;337:1616.
65. Costleigh BJ, Miyamoto CT, Micaily B, Brady LW. Heightened sensitivity of the esophagus to radiation in a patient with AIDS. Am J Gastroenterol 1995;90:812-4.
66. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004;134:489-92.
67. Vallis KA. Glutathione deficiency and radiosensitivity in AIDS patients. Lancet 1991;337:918-9.
68. Takeshita T, Ariizumi-Shibusawa C, Shimizu K, Hoshino H, Yamagata Z, Iijima S, et al. The effect of aging on cell-cycle kinetics and X-ray-induced chromosome aberrations in cultured lymphocytes from patients with Down syndrome. Mutat Res 1992;275:21-9.
69. Harris G, Cramp WA, Edwards JC, George AM, Sabovljev SA, Hart L, et al. Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med 1985;47:689-99.
70. Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 1997;15:2728-35.
71. Cossu F, Rombi G, Aresu G, Pia G, Pascalis L. Radiosensitivity of lymphocyte subpopulations in subjects with systemic lupus erythematosus. An in vitro preliminary study. Minerva Med 1991;82:239-49.
72. West CML. Intrinsic radiosensibility as a predictor of patient response to radiotherapy. Br J Radiol 1995;68:827-37.
73. Fertil B, Malaise EP. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys 1981;7:621-9.
74. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985;11:1699-707.
75. Malaise EP, Fertil B, Deschavanne PJ, Chavaudra N, Brock WA. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiat Res 1987;111:319-33.
76. Deacon J, Peckham MJ, Steel GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 1984;2:317-23.
77. Davidson SE, West CML, Hunter RD. Lack of association between in vitro clonogenic growth of human cervical carcinoma and tumor stage, differentiation, patient age, host cell infiltration or patient survival. Int J Cancer 1992;50:10-4.
78. Lawton PA, Hodgkiss RJ, Eyden BP, Joiner MC. Growth of fibroblast as a potential confounding factor in soft agar clonogenic assays for tumour cell radiosensitivity. Radiother Oncol 1994;12:218-25.
79. Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1993;27:1173-9.
80. Loeffler JS, Harris JR, Dahlberg WK, Little JB. In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer. Radiat Res 1990;121:227-31.
81. Brock WA, Tucker SL, Geara FB, Turesson I, Wike J, Nyman J, et al. Fibroblasts radiosensitivity versus acute and late normal skin responses in breast cancer. Int J Radiat Oncol Biol Phys 1995;32:1371-9.
82. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the subcutaneous fibrosis, telangiectasia and skin erythema after radiotherapy. Radiother Oncol 1996;40:101-9.
83. Rudat V, Dietz A, Conradt C, Weber KJ, Flentje M. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol 1997;43:181-8.
84. Leong T, Borg M, McKay M. Clinical and cellular radiosensitivity in inherited human syndromes. Clin Oncol (R Coll Radiol) 2004;16:206-9.
85. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Evidence for a positive correlation between in vitro rediosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol 1994;66:407-12.
86. Beck-Bornhold HP. Intrinsic radiosensitivity of human fibroblasts seems to be unable to predict normal tissue response to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 32:553-4.
87. Elyan SG, West CML, Roberts SA, Hunter RD. Use of an internal standard in comparative measurements of the intrinsic radiosensitivities of human T-lymphocytes. Int J Radiat Biol 1993;64:385-91.
88. Scott D, Spreadborough A, Levine E, Roberts SA. Genetic predisposition in breast cancer. Lancet 1994;344:1444.
89. Elyan SAG, West CML, Roberts SA and Hunter RD. Use of low-dose rate irradiation to measure the intrinsic radiosensitivity of human T-lymphocytes. Int J Radiat Biol 1993;64:375-84.
90. Sabovljev SA, Cramp WA, Lewis PD, Harris G, Halnan KE, Lambert J. Use of rapid test of cellular radiosensitivity in radiotherapeutic practice. Lancet 1985;2:787.
91. Dunst J, Gebhart E. Unexpected tumor response, radiation myelitis and increased in vitro radio-sensitivity of lymphocytes in a patient with a non-small lung cancer. Radiother Oncol 1995;36:158.
92. Brown JM, Evans J, Kovacs MS. The prediction of human tumor radiosensitivity in situ: an approach using chromosome aberrations detected by fluorescence in situ hybridization. Int J Radiat Oncol Biol Phys 1992;24:279-86.
93. Badie C, Iliakis G, Foray N, Alsbeih G, Pantellias GE, Okayasu R et al. Defective repair of DNA double strand breaks and chomosome damage in fibroblasts from a radiosensitive leukemia patient. Cancer Res 1995;55:1232-4.
94. Neubauer S, Dunst J, Gebhart E. The impact of complex chromosomal rearrangements on the detection of cancer patients. Radiother Oncol 1997;43:189-95.
95. Rothfuss A, Schutz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, et al. Induced micronucleus in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 2000;60:390-4.
96. Slonina D, Klinek M, Szpytma T and Gasinska A. Comparison of normal tissue cells with normal tissue reactions after radiotherapy. Int J Radiat Biol 2000;76:1255-64.
97. Leong T, Whitty J, Keilar M, Mifsud S, Ramsay J, Birrell G, et al. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitivity cancer patients. Int J Radiat Oncol Biol Phys 2000;48:959-65.
98. Price EA, Bourne SL, Radbourne R, Lawton PA, Lamerdin J, Thompson LH, et al. Rare microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somatic Cell Mol Genet 1997;23:237-47.
99. Catena C, Parasacchi P, Conti D, Sgura A, Trenta G, Righi E, et al. Peripheral blood lymphocyte decrease and micronucleus yields during radiotherapy. Int J Radiat Biol 1997;72:575-85.
100. Di Giorgio M, Sardi M, Busto E, Vallerga MB, Taja MR, Mairal L. Assessment of individual radiosensitivity in human lymphocytes using micronucleus and microgel electrophoresis "Comet" assays. In: Proceedings of the 11th international congress of the International Radiation Protection Association (IRPA-11), 23-28 May 2004, Madrid.
101. Lee T-K, Allison RR, O'Brien KF, Johnke RM, Christie KI, Naves JL, et al. Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity. Int J Radiat Oncol Biol Phys 2003;57:222-9.
102. Leprat F, Alapetite C, Rosselli F, Ridet A, Schlumberger M, Sarasin A, et al. Impaired DNA repair as assessed by the "comet" assay in patients with thyroid tumors after a history of radiation therapy; a preliminary study. Int J Radiat Oncol Biol Phys 1998;40:1019-26.
103. McCurdy D, Tai LQ, Frias S, Wang Z. Delayed repair of DNA damage by ionizing radiation in cells from patients with systemic lupus erythematosus and rheumatoid arthritis. Radiat Res 1997;147:48-54.
104. Alapetite C, Thirion P, de la Rochefordiere A, Cosset JM, Moustacchi E. Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer 1999;83:83-90.
105. Zhang H, Buchholz TA, Hancock D, Spitz MR, Wu X. Gamma induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. Int J Oncol 2000;2:399-404.
106. Schindewolf C, Lobenwein K, Trinczek K, Gomolka M, Soewarto D, Fella C, et al. Comet assay as a tool for mouse models with inherited radiation sensitivity. Mamm Genome 2000;11:552-4.
107. Kiltie AE, Ryan AJ, Swindell R, Barber JBP, West CML, Magee B, et al. A correlation between residual radiation-induced double-strand breaks in cultured fibroblast and late radiotherapy reactions in breast cancer patients. Radiother Oncol 1999;51:55-65.
108. Kiltie AE, Barber JB, Swindell R, Ryan AJ, West CM, Hendry JH, et al. Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patients. Int J Radiat Oncol Biol Phys 1999;43:481-7.
109. Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother Oncol 2002;64:131-40.
110. Andreassen CN, Alsner J, Overgaard M, Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 2003;69:127-35.
111. Duchaud E, Ridet A, Stoppa-Lyonnet D, Janin N, Moustacchi E, Rosselli F. Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Cancer Res 1996;56:1400-4.
112. Ozsahin M, Ozsahin H, Shi Y, Larsson B, Würgler FE, Crompton NEA. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol 1997;38:429-40.
113. Ozsahin M, Miralbell R, Emery GC, Shi Y, Wellmann D, Coucke PA, et al. Profils apoptotiques altérés chez les patients irradiés montrant une hypersensibilité. Cancer Radiothér 1998;2:550.
114. Rached E, Schindler R, Beer KT, Vetterli D, Greiner RH. No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy. Eur J Cancer 1998;34:378-83.
115. Li Ch, Wilson PB, Levine E, Barber J, Stewart A, Kumar S. TGF-β1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer (Pred Oncol) 1999;84:155-9.
116. Annals of the International Commission on Radiological Protection. ICRP Publication No. 79: genetic susceptibility to cancer. Elmsford: Pergamon; 1998.
117. Kony SJ, de Vathaire F, Chompret A, Shamsaldim A, Grimaud E, Raquin MA, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997;350:91-5.